Minority News
The world you see depends upon the news you get. ®
May 19, 2024
After Launching Massive Camp Giveaway for NYC Families Affected by "Summer Rising" Crisis, Brains & Motion Education (BAM!)   •     •   L.A. Care and Blue Shield of California Promise Health Plans Unveil New, Vibrant Community Resource Center in Panorama City with  •     •   Aramco and Spiritus to Advance Direct Air Capture Technology, Investment by Aramco Ventures   •     •   Sacred Heart Celebrates 125th Anniversary   •     •   Avangrid to Be Acquired by Iberdrola   •     •   HERImpact: Entrepreneurship for Impact Program Kicks Off in Chicago, Empowering Women Entrepreneurs   •     •   Federal, provincial and territorial ministers gather to support culture and heritage at annual meeting   •     •   Dillard’s, Inc. Announces $0.25 Cash Dividend   •     •   Historic Inaugural Class Graduates from OSU College of Osteopathic Medicine at the Cherokee Nation   •     •   The AZEK Company Receives NYSE Notice Regarding Filing of Form 10-Q for the Fiscal Quarter Ended March 31, 2024   •     •   Angels Helpers NYC 2024 Charity Gala Raises Funds for Harlem School of the Arts, Highbridge Voices   •     •   Upneeq® Wins 2024 Shape Skin Award, “Best for Lift”, in the Professional Treatment Category   •     •   Red Door Community Raises more than $300,000 at Their Annual Luncheon Celebrating Women Working and Living with Cancer   •     •   Historic Bellevue House reopens   •     •   Energy Vault Holdings, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08   •     •   Rockwell Institute Celebrates Highest Real Estate Exam Pass Rates for First-Time Test Takers in the State of Washington   •     •   May and Stanley Smith Charitable Trust Partners with American Indian College Fund to Support Native Student Veterans   •     •   Statement by the Prime Minister on Tamil Genocide Remembrance Day   •     •   WOMEN'S HEALTHCARE COMPANY WATKINS-CONTI RECEIVES FDA 510(K) CLEARANCE FOR NEW STRESS URINARY INCONTINENCE DEVICE YŌNI.FIT&  •     •   Xylem Inc. Declares Second Quarter Dividend of 36 Cents per Share   •  
HOME SEARCH SUBSCRIBE CONTACT

Children's Hospital Colorado Provides Guidance to Families for Navigating National Asthma Medication Changes

Children's Hospital Colorado Provides Guidance to Families for Navigating National Asthma Medication Changes

PR Newswire

Discontinuation of inhaler production impacts asthma management and treatment plans for kids and medical providers

AURORA, Colo., May 7, 2024 /PRNewswire/ -- Today, Children's Hospital Colorado (Children's Colorado) is sharing guidance for families who are impacted by the discontinuation Flovent inhaler production and who may be struggling to keep their asthma symptoms under control. The halt in production of this common asthma treatment was sudden and announced after most insurance covered drug formularies (lists) for 2024 were finalized. As a result, many patients with asthma may not only be struggling to manage their asthma, but also be forced to pay high out-of-pocket costs for asthma treatment alternatives that may not be as effective. This change is especially difficult for children because many of the medication delivery devices on the market do not work in young children. As a result, some families may also, due to this new barrier, be grappling with not having access to asthma management medications.

"We are now seeing the trickle-down effect of patients not being able to manage their asthma day-to-day," said Monica Federico, MD, pulmonologist at Children's Colorado. "It's especially difficult for families who do not speak English fluently. It's difficult to explain why sudden changes have been made in a child's treatment and why they don't have access to a product that can help. This is creating barriers to kids being able to be healthy."

Experts in the Breathing Institute at Children's Colorado want parents and caregivers to be on guard about these new risks and understand how sudden changes in treatment can impact a child's health. These impacts are:

These sudden changes in inhaler production or insurance coverage are also creating barriers for health care providers. It can take hours each day for providers to find medications that are available in the pharmacy and are covered by a patient's health insurance.

"We were given limited notice on the production changes and insurance coverage for these inhalers which so many children use," said Catherine Clark, PCNS-BC, nurse specialist at the Children's Colorado Health Pavilion. "Now, kids are being put in a situation where they may be given an asthma medication or device that is not appropriate for their age, causing them to lose control of their asthma."

While these medication changes can be difficult for families, there is hope on the horizon. Three of the four major asthma inhaler production companies made the decision to cap the price of their inhalers at $35. This came following an investigation in January 2024 by the U.S. Senate Committee on Health, Education, Labor and Pensions into high prices for inhalers in the United States compared to other countries.

Price changes will start going into effect on June 1, 2024, through Jan. 1, 2025. Families will continue to see asthma medication changes in their insurance coverage until early 2025, and may also see additional shortages as they encounter backorders and demand for alternative products meant for pediatric use. As these challenges occur, the Children's Colorado Asthma team would like to provide action steps families can take:

Please reach out to media@childrenscolorado.org for an interview with an expert who can speak to the experience providers and families are having. There are interview opportunities in both English and Spanish.

ABOUT CHILDREN'S HOSPITAL COLORADO

Children's Hospital Colorado is one of the nation's leading and most expansive nonprofit pediatric healthcare systems with a mission to improve the health of children through patient care, education, research and advocacy. Founded in 1908 and ranked among the best children's hospitals in the nation as recognized by U.S. News & World Report, Children's Colorado has established itself as a pioneer in the discovery of innovative and groundbreaking treatments that are shaping the future of pediatric healthcare worldwide. Children's Colorado offers a full spectrum of family-centered care at its urgent, emergency and specialty care locations throughout Colorado, including an academic medical center on the Anschutz Medical Campus in Aurora, hospitals in Colorado Springs, Highlands Ranch and Broomfield, and outreach clinics across the region. For more information, visit www.childrenscolorado.org or connect with us on FacebookInstagram and YouTube

Children's Hospital Colorado complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex.

ATENCIÓN: si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-720-777-9800.

CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-720-777-9800.

Media Contacts:

Courtney Mally, Children's Hospital Colorado

24/7 media line: 303-890-8314

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/childrens-hospital-colorado-provides-guidance-to-families-for-navigating-national-asthma-medication-changes-302137455.html

SOURCE Children's Hospital Colorado